BioAtla logo
BioAtla BCAB
$ 1.4 -5.69%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

BioAtla Balance Sheet 2011-2024 | BCAB

Annual Balance Sheet BioAtla

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-109 M -212 M -240 M -237 M 14.4 M 4.14 M - - - - - - -

Long Term Debt

836 K 2.46 M 3.98 M 682 K 8.41 M 15 M - - - - - - -

Long Term Debt Current

1.62 M 1.52 M 1.39 M - - - - - - - - - -

Total Non Current Liabilities

- - - 2.7 M 38.6 M 35.9 M - - - - - - -

Total Current Liabilities

28.3 M 23.1 M 19.8 M - - - - - - - - - -

Total Liabilities

49 M 45.4 M 43.6 M 35 M 65.3 M 45.1 M - - - - - - -

Deferred Revenue

- - - 19.8 M 1.42 M 169 K - - - - - - -

Retained Earnings

-416 M -293 M -186 M -90.9 M -148 M -119 M - - - - - - -

Total Assets

120 M 226 M 254 M 245 M 9.34 M 16.6 M - - - - - - -

Cash and Cash Equivalents

111 M 216 M 245 M - - - - - - - - - -

Book Value

70.7 M 180 M 211 M 210 M -56 M -28.4 M - - - - - - -

Total Shareholders Equity

70.7 M 180 M 211 M 210 M - - - - - - - - -

All numbers in USD currency

Quarterly Balance Sheet BioAtla

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

- - 415 K 836 K 1.25 M 1.66 M 2.06 M 2.46 M 2.85 M 3.23 M 3.61 M 3.98 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

39.3 M 37.3 M 39.5 M 49 M 56.7 M 55.1 M 48.1 M 45.4 M 46.5 M 48.5 M 40.6 M 43.6 M 46.9 M 38.7 M 33.2 M 35 M 35 M 35 M 35 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Deferred Revenue

- - - - - - - - - - - - 19.8 M 19.8 M 19.8 M 19.8 M 19.8 M 19.8 M 19.8 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

-471 M -461 M -439 M -416 M -389 M -356 M -320 M -293 M -265 M -239 M -211 M -186 M -163 M -140 M -110 M -90.9 M -90.9 M -90.9 M -90.9 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Assets

62.2 M 68.6 M 89.2 M 120 M 151 M 180 M 205 M 226 M 189 M 213 M 231 M 254 M 278 M 217 M 229 M 245 M 245 M 245 M 245 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash and Cash Equivalents

56.5 M 61.7 M 80.6 M 111 M 141 M 169 M 193 M 216 M 178 M 202 M 219 M 245 M 270 M 208 M 221 M 239 M 239 M 239 M 239 M 3.7 M - - - 10.9 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Book Value

23 M 31.4 M 49.7 M 70.7 M 94.7 M 125 M 156 M 180 M 143 M 165 M 190 M 211 M 231 M 178 M 196 M 210 M 210 M 210 M 210 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Shareholders Equity

23 M 31.4 M 49.7 M 70.7 M 94.7 M 125 M 156 M 180 M 143 M 165 M 190 M 211 M 231 M 178 M 196 M 210 M 210 M 210 M 210 M -56 M - - - -28.4 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency